Frequently Asked Questions
The market is segmented based on , By Type (Vitamins and Dietary Supplements, Steroids and Immunosuppressive Drugs, Therapeutic Vaccines), End-User (Hospitals and Clinics, Clinical Research Organizations, Research & Academic Institutes), Drugs (First Line of Treatment, Second Line of Treatment), Enzyme Type (Distension, Diarrhoea, Anorexia, Bloating, Gas, Fatigue, Others), Distribution Channel (Hospital, Research Centres, Clinics, Others) - Industry Trends and Forecast to 2030.
.
The Global Celiac Disease Treatment Market size was valued at USD 795.00 USD Million in 2022.
The Global Celiac Disease Treatment Market is projected to grow at a CAGR of 10.84% during the forecast period of 2023 to 2030.
The major players operating in the market include Amgen , Amneal Pharmaceuticals LLC, BioLineRx Ltd, Calypso Biotech, Freedom Foods Group Limited, General Mills , Glenmark Pharmaceuticals, Hain Celestial, 9 Meters Biopharma , Kellogg Co, Mondelez International, Mylan N.V, Pinnacle Foods , Selecta Biosciences , Takeda Pharmaceutical Company Limited, The Kraft Heinz Company, Hikma Pharmaceuticals PLC, ZEDIRA GmbH.
The market report covers data from the U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America.
